Answers are grounded in this paper and cite their sources.
Objectives: This prospective study aimed to assess the 1-year outcomes of transepithelial [epithelium-on (Epi-on)] corneal collagen cross-linking (CXL) with supplemental oxygen in patients with progressive keratoconus (KC) in Oman.The study sought to assess efficacy, and effectivity associated with this modified CXL technique.Methods: A total of 50 eyes of 35 patients with progressive KC underwent Epi-on CXL with supplemental oxygen.Clinical evaluations were performed at various time intervals over 1 year, assessing parameters including uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), corneal thickness, and keratometry.The demarcation line depth was also measured. Results:The results revealed non-significant improvements in UCVA, modest enhancements in BCVA, and corneal thickness stabilization.Notably, keratometry parameters showed initial increases followed by reductions, with a significant decrease in K-mean.The demarcation line reached an average depth of 333.18 microns, signifying deep cross-linking equivalent to conventional CXL.Conclusion: Transepithelial cross-Linking with supplemental oxygen shows promise in halting the progression of KC.The approach, which avoids epithelial removal, proves effective in stabilizing corneal shape and improving visual acuity.Particularly beneficial for younger patients, this modified CXL technique offers a less invasive alternative to conventional methods, thereby enhancing the management of progressive KC.While further research is needed for validation, current evidence positions transepithelial CXL as a valuable advancement with the potential to significantly impact the treatment landscape for KC.
No takes yet. Share an insight, caveat, or question.
Rashid Al Saidi (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: